Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Publication year range
1.
Asian Pac J Trop Med ; 5(5): 358-61, 2012 May.
Article in English | MEDLINE | ID: mdl-22546651

ABSTRACT

OBJECTIVE: To find out the in vitro antiplasmodial activities of mangrove leaf extracts. METHODS: In vitro antiplasmodial assay was carried out with 13 different mangrove plants. Column chromatography was performed with the most potent Agecerious corniculatum (A. corniculatum) by using various solvent extractions. GC-MS was also preformed with the most potent ethanolic fraction of the A. corniculatum extract. RESULTS: Of the 13 mangroves plants, A. corniculatum showed maximum percentage of parasitemia suppression (94.98 ± 1.16)%. Column chromatography was performed with A. corniculatum with different solvents and the methanolic extract showed maximum percentage (99.73±1.63)% of parasitemia inhibition at 150 µg/mL concentration with the IC(50) value of (29.28±3.23) µg/mL concentration. The results of the GC-MS analysis observed that, the most potent methanolic extract showed maximum retention time (30.687 RT) and the chemical class was identified as Spiro [benzofuran-2(3 H), 1'(3 cyclohexane)-2',3-dione, 7-chloro-4',6] which was responsible for the antiplasmodial activity. CONCLUSIONS: It is concluded from the present study that, the chemical constituents of A. corniculatum collected from Pichavaram mangrove forest can be used as a putative antiplasmodial drugs in future.


Subject(s)
Antimalarials/pharmacology , Benzofurans/pharmacology , Phytotherapy/methods , Plant Extracts/pharmacology , Plasmodium falciparum/drug effects , Primulaceae , Chromatography , Erythrocytes/parasitology , Humans , Malaria, Falciparum/drug therapy , Parasitemia/drug therapy , Parasitic Sensitivity Tests/methods , Plant Leaves
2.
Asian Pac J Trop Med ; 5(2): 103-6, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22221750

ABSTRACT

OBJECTIVE: To identify the possible antiplasmodial compounds from leaf, stem, root and flower extracts of Ocimum canum (O. canum), Ocimum sanctum (O. sanctum) and Ocimum basilicum (O. basilicum). METHODS: The O. canum, O. sanctum and O. basilicum were collected from Ramanathapuram District, Tamil Nadu and the extraction was carried out in ethanol. The filter sterilized extracts (100, 50, 25, 12.5, 6.25 and 3.125 µg/mL) of leaf, stem, root and flower extracts of O. canum, O. sanctum and O. basilicum were tested for antiplasmodial activity against Plasmodium falciparum (P. falciparum). The potential extracts were also tested for their phytochemical constituents. RESULTS: The leaf extract of O. sanctum showed excellent antiplasmodial activity (IC(50) 35.58 µg/mL) followed by leaf extract of O. basilicum (IC(50) 43.81 µg/mL). The leaf extract of O. canum, root extracts of O. sanctum and O. basilicum, the stem and flower extracts of all the three tested Ocimum species showed IC(50) values between 50 and 100 µg/mL. Statistical analysis reveals that, significant antiplasmodial activity (P <0.01) was observed between the concentrations and time of exposure. The chemical injury to erythrocytes was also carried out and it shows that, there were no morphological changes in erythrocytes by the ethanolic extract of O. canum, O. sanctum and O. basilicum. The in vitro antiplasmodial activity might be due to the presence of alkaloids, glycosides, flavonoids, phenols, saponins, triterpenoids, proteins, resins, steroids and tannins in the ethanolic extracts of tested plants. CONCLUSIONS: The ethanolic leaf extracts of O. sanctum possess lead compounds for the development of antiplasmodial drugs.


Subject(s)
Antimalarials/pharmacology , Erythrocytes/drug effects , Malaria, Falciparum/drug therapy , Ocimum/chemistry , Plant Extracts/pharmacology , Plasmodium falciparum/drug effects , Drug Discovery , Ethanol , Flowers/chemistry , Humans , Plant Bark/chemistry , Plant Leaves/chemistry , Plants, Medicinal/chemistry , Solvents
3.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-500541

ABSTRACT

Objective: To investigate the crude extract of marine actinomycetes with adverse effect locally on the adult Wister albino rats or systematically in the blood circulation. Methods: Acute toxicity, sub acute toxicity, biochemical and histopathological were tested. Results: In the results acute toxicity (LD50=2 500 μg/kg bw), sub acute toxicity study (2 500 μg/kg bw) were significant at 5% level of each experimental groups compared to the control group. Biochemical and histopathological study also showed better as compared with control group Conclusion:This crude microbial extract from Streptomyces sp. RSAUT 20 and Streptomyces scabiei (S. scabiei) RSAUK 49 is potential source for novel antimicrobial compounds. The crude extract of Streptomyces sp. RSAUT 20 and S. scabiei RSAUK 49 were tested for in vivo toxicity study.

4.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-500566

ABSTRACT

Objective: To identify the hepatoprotective and in vitro antioxidant activity of Lumnitzera racemosa (L. racemosa) leaf extract. Methods: Animals in Group 1 served as vehicle control, Group 2 served as hepatotoxin (CCL4 treated) group, Group 3 served as positive control (Silymarin) group, and Group 4, 5 and 6 served as (75, 150 and 300 mg/kg bw p.o.) L. racemosa leaf extract treated groups. Moreover, in vitro antioxidant DPPH, hydroxyl radical scavenging activity (HRSA), NO, ferric reducing antioxidant power (FRAP), lipid hydroperoxide (LPO) and super oxide dismutase (SOD) were also analyzed for the leaf extract. Results: The levels of the serum parameters such as serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), bilirubin, cholesterol (CHL), sugar and lactate dehydrogenase (LDH) were significantly increased in CCL4 treated rats when compared with the control group (P<0.05). But the L. racemosa leaf extract treated rats showed maximum reduction of SGOT [(210.36±19.63) IU/L], SGPT [(82.37±13.87) IU/L], ALP [(197.63±23.43) IU/L], bilurubin [(2.15±0.84) mg/dL], cholesterol [(163.83±15.63) mg/dL], sugar [(93.00±7.65) mg/dL] and LDH [(1134.00±285.00) IU/L] were observed with the high dose (300 mg/kg bw) of leaf extract treated rats. Histopathological scores showed that, no visible changes were observed with high dose (300 mg/kgbw) of leaf extract treated rats except few mild necrosis. The IC50 values were observed as (56.37±4.87) μg/mL, (57.68±1.98) μg/mL, (64.15±2.90) μg/mL, (61.94±3.98) μg/mL, (94.53±1.68) μg/mL and (69.7±2.65) μg/mL for DPPH, HRSA, NO, FRAP, LPO and SOD radical scavenging activities, respectively. Conclusions: In conclusion, the hepatoprotective effect of the L. racemosa leaf extract might be due to the presence of phenolic groups, terpenoids and alkaloids and in vitro antioxidant properties.

5.
Article in English | WPRIM (Western Pacific) | ID: wpr-820109

ABSTRACT

OBJECTIVE@#To identify the hepatoprotective and antioxidant activity of Luminetzera racemosa (L. racemosa) bark extract.@*METHODS@#Wistar albino rats were divided into 6 groups: Group 1 served as control; Group 2 served as hepatotoxin (CCL(4) treated) group; Group 3 served as positive control (Silymarin) treated groups; Group 4, 5 and 6 served as (100, 200 and 300 mg/kg bw p.o.) L. racemosa bark extract treated groups. Moreover, in vitro antioxidant indexes, including DPPH, hydroxyl radical scavenging activity (HRSA), NO, ferric reducing antioxidant power (FRAP), lipid hydroperoxide (LPO) and super oxide dismutase (SOD) were also analyzed in the bark extract.@*RESULTS@#The results suggested that, the level of serum glutamate oxyloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatise (ALP), bilurubin, cholesterol, sugar and lactate dehydrogenase (LDH) were significantly (P<0.05) increased in hepatotoxin treated rats when compared with the control group. But, the maximum reduction of SGOT [(225.36±13.65) IU/L], SGPT [(96.85±17.36) IU/L], ALP [(315.37±17.16) IU/L], bilirubin [(2.97±0.46) mg/dL], cholesterol [(163.73±17.54) mg/dL], sugar [(127.35±27.35) mg/dL] and LDH [(1 784.00±268.36) IU/L] were observed with 300 mg/kg bw of bark extract treated rats. Histopathological scores showed that, no visible changes were observed with high dose (300 mg/kg bw) of bark extract treated rats except mild fatty changes. The in vitro antioxidant assays showed that, the IC(50) values were observed as (44.17±6.87) μg/mL, (42.45±2.81)μg/mL, (62.37±3.98)μg/mL, (54.24±3.09)μg/mL, (87.25±5.90) μg/mL and (71.54±5.42)μg/mL for DPPH, HRSA, NO, FRAP, LPO and SOD radical scavenging activities, respectively.@*CONCLUSIONS@#The hepatoprotective and antioxidant activities of the bark extract might be to the presence of unique chemical classes such as flavonoids, alkaloids and polyphenols.


Subject(s)
Animals , Rats , Alanine Transaminase , Blood , Antioxidants , Pharmacology , Aspartate Aminotransferases , Blood , Carbon Tetrachloride , Toxicity , Liver , Plant Bark , Plant Extracts , Pharmacology , Rats, Wistar , Salt-Tolerant Plants
6.
Article in English | WPRIM (Western Pacific) | ID: wpr-335020

ABSTRACT

<p><b>OBJECTIVE</b>To identify the hepatoprotective and in vitro antioxidant activity of Lumnitzera racemosa (L. racemosa) leaf extract.</p><p><b>METHODS</b>Animals in Group 1 served as vehicle control, Group 2 served as hepatotoxin (CCL4 treated) group, Group 3 served as positive control (Silymarin) group, and Group 4, 5 and 6 served as (75, 150 and 300 mg/kg bw p.o.) L. racemosa leaf extract treated groups. Moreover, in vitro antioxidant DPPH, hydroxyl radical scavenging activity (HRSA), NO, ferric reducing antioxidant power (FRAP), lipid hydroperoxide (LPO) and super oxide dismutase (SOD) were also analyzed for the leaf extract.</p><p><b>RESULTS</b>The levels of the serum parameters such as serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), bilirubin, cholesterol (CHL), sugar and lactate dehydrogenase (LDH) were significantly increased in CCL4 treated rats when compared with the control group (P<0.05). But the L. racemosa leaf extract treated rats showed maximum reduction of SGOT [(210.36±19.63) IU/L], SGPT [(82.37±13.87) IU/L], ALP [(197.63±23.43) IU/L], bilurubin [(2.15±0.84) mg/dL], cholesterol [(163.83±15.63) mg/dL], sugar [(93.00±7.65) mg/dL] and LDH [(1134.00±285.00) IU/L] were observed with the high dose (300 mg/kg bw) of leaf extract treated rats. Histopathological scores showed that, no visible changes were observed with high dose (300 mg/kg bw) of leaf extract treated rats except few mild necrosis. The IC50 values were observed as (56.37±4.87) µg/mL, (57.68±1.98) µg/mL, (64.15±2.90) µg/mL, (61.94±3.98) µg/mL, (94.53±1.68) µg/mL and (69.7±2.65) µg/mL for DPPH, HRSA, NO, FRAP, LPO and SOD radical scavenging activities, respectively.</p><p><b>CONCLUSIONS</b>In conclusion, the hepatoprotective effect of the L. racemosa leaf extract might be due to the presence of phenolic groups, terpenoids and alkaloids and in vitro antioxidant properties.</p>


Subject(s)
Animals , Male , Rats , Antioxidants , Pharmacology , Therapeutic Uses , Carbon Tetrachloride , Toxicity , Chemical and Drug Induced Liver Injury , Drug Therapy , Pathology , Liver , Chemistry , Pathology , Plant Extracts , Chemistry , Plant Leaves , Chemistry , Protective Agents , Pharmacology , Therapeutic Uses , Rats, Wistar , Rhizophoraceae , Chemistry
SELECTION OF CITATIONS
SEARCH DETAIL